Driskell Bioengineering

Driskell Bioengineering is a biotechnology company focused on developing regenerative medicine solutions for skin health and wound healing. Founded by Dr. Ryan Driskell, the company leverages advanced insights into fibroblast heterogeneity and spatial transcriptomics to reprogram adult skin cells into a regenerative state. Their primary goal is to enable scarless healing and restore functional skin structures, such as hair follicles and sweat glands, in patients with chronic wounds or severe scarring. The company's research-driven approach aims to transform the standard of care for dermatology and surgical recovery by utilizing developmental biology principles to trigger adult skin regeneration.